GRANULES.NS Balance Sheet
Granules India Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 22:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹1,631.37 Cr. | ₹1,856.09 Cr. | ₹2,217.42 Cr. | ₹3,051.41 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹228.04 Cr. | ₹259.54 Cr. | ₹436.95 Cr. | ₹406.49 Cr. | CapitalWorkInProgress |
| Goodwill | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹11.65 Cr. | Goodwill |
| Other Intangible Assets | ₹279.55 Cr. | ₹239.53 Cr. | ₹209.04 Cr. | ₹187.05 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹21.21 Cr. | ₹21.52 Cr. | ₹22.04 Cr. | ₹0.84 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹142.63 Cr. | ₹173.30 Cr. | ₹160.04 Cr. | ₹206.02 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹2,330.42 Cr. | ₹2,615.93 Cr. | ₹3,137.08 Cr. | ₹3,952.30 Cr. | NoncurrentAssets |
| Inventories | ₹1,149.41 Cr. | ₹1,300.55 Cr. | ₹1,342.82 Cr. | ₹1,673.03 Cr. | Inventories |
| Trade Receivables | ₹948.54 Cr. | ₹985.83 Cr. | ₹942.22 Cr. | ₹909.37 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹291.56 Cr. | ₹381.10 Cr. | ₹466.11 Cr. | ₹880.24 Cr. | CashAndCashEquivalents |
| Current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | CurrentInvestments |
| Other Current Assets | ₹160.24 Cr. | ₹229.38 Cr. | ₹232.62 Cr. | ₹231.72 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹2,574.15 Cr. | ₹2,905.05 Cr. | ₹3,115.48 Cr. | ₹3,767.65 Cr. | CurrentAssets |
| Total Assets | ₹4,904.56 Cr. | ₹5,520.98 Cr. | ₹6,252.56 Cr. | ₹7,719.95 Cr. | Assets |
| Equity Share Capital | ₹24.20 Cr. | ₹24.24 Cr. | ₹24.25 Cr. | ₹24.78 Cr. | EquityShareCapital |
| Other Equity | ₹2,810.70 Cr. | ₹3,201.31 Cr. | ₹3,691.32 Cr. | ₹5,060.22 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹2,834.91 Cr. | ₹3,225.54 Cr. | ₹3,715.58 Cr. | ₹5,084.99 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | N/A | NonControllingInterest |
| Total Equity | ₹2,834.91 Cr. | ₹3,225.54 Cr. | ₹3,715.58 Cr. | ₹5,084.99 Cr. | Equity |
| Long-term Borrowings | ₹148.64 Cr. | ₹68.97 Cr. | ₹311.51 Cr. | ₹297.15 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹256.15 Cr. | ₹213.15 Cr. | ₹533.82 Cr. | ₹542.92 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹909.98 Cr. | ₹1,154.26 Cr. | ₹974.27 Cr. | ₹1,040.98 Cr. | BorrowingsCurrent |
| Trade Payables | ₹782.12 Cr. | ₹749.53 Cr. | ₹726.07 Cr. | ₹672.80 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹15.14 Cr. | ₹26.13 Cr. | ₹226.91 Cr. | ₹41.61 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹1,813.50 Cr. | ₹2,082.29 Cr. | ₹2,003.16 Cr. | ₹2,092.03 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹4,904.56 Cr. | ₹5,520.98 Cr. | ₹6,252.56 Cr. | ₹7,719.95 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from GRANULES.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).